ATE284204T1 - Lipidkomplexe von sehr unlöslichen platinkomplexen - Google Patents

Lipidkomplexe von sehr unlöslichen platinkomplexen

Info

Publication number
ATE284204T1
ATE284204T1 AT98903358T AT98903358T ATE284204T1 AT E284204 T1 ATE284204 T1 AT E284204T1 AT 98903358 T AT98903358 T AT 98903358T AT 98903358 T AT98903358 T AT 98903358T AT E284204 T1 ATE284204 T1 AT E284204T1
Authority
AT
Austria
Prior art keywords
complexes
lipid
insoluble platinum
insoluble
platinum complexes
Prior art date
Application number
AT98903358T
Other languages
English (en)
Inventor
Mathew Cherian
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE284204T1 publication Critical patent/ATE284204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98903358T 1997-02-05 1998-01-28 Lipidkomplexe von sehr unlöslichen platinkomplexen ATE284204T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3737797P 1997-02-05 1997-02-05
PCT/US1998/000035 WO1998033481A1 (en) 1997-02-05 1998-01-28 Lipid complexes and liposomes of highly insoluble platinum complexes

Publications (1)

Publication Number Publication Date
ATE284204T1 true ATE284204T1 (de) 2004-12-15

Family

ID=21894020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903358T ATE284204T1 (de) 1997-02-05 1998-01-28 Lipidkomplexe von sehr unlöslichen platinkomplexen

Country Status (22)

Country Link
US (1) US6287593B2 (de)
EP (1) EP0975329B1 (de)
JP (1) JP2002513396A (de)
KR (1) KR100578705B1 (de)
CN (2) CN1096263C (de)
AT (1) ATE284204T1 (de)
AU (1) AU749220B2 (de)
BR (1) BR9815445A (de)
CA (1) CA2279279C (de)
DE (1) DE69828038T2 (de)
DK (1) DK0975329T3 (de)
EA (1) EA002630B1 (de)
ES (1) ES2234094T3 (de)
HK (1) HK1054201B (de)
HU (1) HUP0001266A3 (de)
IL (1) IL131008A (de)
NO (1) NO993750D0 (de)
NZ (1) NZ337502A (de)
PL (1) PL192633B1 (de)
PT (1) PT975329E (de)
UA (1) UA71540C2 (de)
WO (1) WO1998033481A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598474B1 (ko) 1998-04-03 2006-07-11 아지노모토 가부시키가이샤 항종양제
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US20070160656A1 (en) * 2003-05-02 2007-07-12 Dziewiszek Krzysztof J Lipid platinum complexes and methods of use thereof
US20080050425A1 (en) * 2003-05-20 2008-02-28 Jonathan Lewis Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex
AU2003239510A1 (en) * 2003-05-20 2005-01-21 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising gemcitabine and a liposomal platinum complex
AU2003233586A1 (en) * 2003-05-20 2005-01-21 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising capecitabine and a liposomal platinum complex
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
CA2560900A1 (en) * 2004-03-26 2005-10-06 Cell Therapeutics Europe S.R.L. Nanoparticle formulations of platinum compounds
WO2006084248A2 (en) * 2005-02-04 2006-08-10 Antigenics, Inc. Compositions comprising a platinum complex, lipid, and surfactant
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
AU2006321796A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
EP2481396A4 (de) * 2009-09-21 2014-03-05 Jw Pharmaceutical Corp Oxaliplatin-nanopartikel und herstellungsverfahren dafür
WO2012006101A2 (en) 2010-06-28 2012-01-12 The General Hospital Corporation Blood substitutes and uses thereof
CN102276674A (zh) * 2011-06-24 2011-12-14 天津大学 用于肿瘤靶向治疗的含半乳糖铂配合物及其制备方法
CN102286050A (zh) * 2011-06-24 2011-12-21 天津大学 用于肿瘤靶向治疗的含葡萄糖铂配合物及其制备方法
CN102286049A (zh) * 2011-06-24 2011-12-21 天津谷堆生物医药科技有限公司 用于肿瘤治疗的水溶性铂配合物及其制备方法
CN102716145A (zh) * 2012-06-20 2012-10-10 天津谷堆生物医药科技有限公司 含糖铂配合物在制备防治肿瘤药物的用途
JP2015524411A (ja) 2012-07-18 2015-08-24 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． エポキシケトン系プロテアソーム阻害剤のリポソーム組成物
PL2892524T3 (pl) 2012-09-04 2021-10-25 Eleison Pharmaceuticals, Llc Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
US10039716B2 (en) 2013-03-13 2018-08-07 Mallinckrodt Llc Liposomal cisplatin compositions for cancer therapy
CN104546722B (zh) * 2015-02-10 2017-05-24 中国医学科学院医药生物技术研究所 米铂脂质体和制法
CN109678910B (zh) * 2016-01-25 2021-09-07 沈阳药科大学 一种化合物及其应用以及一种铂类配合物及其脂质体
EP3538546B1 (de) 2016-11-14 2025-01-08 Novartis AG Zusammensetzungen, methoden und therapeutische verwendungen des fusogenen proteins minion
CN114652680A (zh) * 2020-12-24 2022-06-24 沈阳药科大学 制备脂质体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113508A1 (de) 1982-11-04 1984-07-18 Inco Research & Development Center, Inc. Hydrophobische Platinverbindungen und ihre Herstellung
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
CA1339034C (en) * 1988-08-22 1997-04-01 Paul A. Tremblay Platinum complexes of single isomer neoalkyl acids
US5393909A (en) 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
JPH03200795A (ja) 1989-12-28 1991-09-02 Nippon Kayaku Co Ltd 脂質親和性白金錯体及びそれを含有する製剤
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes

Also Published As

Publication number Publication date
CN1422619A (zh) 2003-06-11
EA199900715A1 (ru) 2000-04-24
PT975329E (pt) 2005-03-31
NO993750L (no) 1999-08-03
IL131008A0 (en) 2001-01-28
HK1054201B (zh) 2005-09-09
IL131008A (en) 2003-06-24
JP2002513396A (ja) 2002-05-08
HK1054201A1 (en) 2003-11-21
DK0975329T3 (da) 2005-03-14
ES2234094T3 (es) 2005-06-16
BR9815445A (pt) 2001-09-25
KR20000070771A (ko) 2000-11-25
US20010010822A1 (en) 2001-08-02
AU6015498A (en) 1998-08-25
EP0975329A1 (de) 2000-02-02
AU749220B2 (en) 2002-06-20
HUP0001266A2 (hu) 2000-11-28
CN1191067C (zh) 2005-03-02
DE69828038T2 (de) 2005-11-03
HK1029059A1 (zh) 2001-03-23
NZ337502A (en) 2001-02-23
UA71540C2 (uk) 2004-12-15
US6287593B2 (en) 2001-09-11
EP0975329B1 (de) 2004-12-08
NO993750D0 (no) 1999-08-03
HUP0001266A3 (en) 2001-02-28
CA2279279A1 (en) 1998-08-06
KR100578705B1 (ko) 2006-05-12
DE69828038D1 (de) 2005-01-13
PL334940A1 (en) 2000-03-27
CN1096263C (zh) 2002-12-18
EA002630B1 (ru) 2002-08-29
CA2279279C (en) 2008-10-14
WO1998033481A1 (en) 1998-08-06
CN1264295A (zh) 2000-08-23
PL192633B1 (pl) 2006-11-30

Similar Documents

Publication Publication Date Title
DE69828038D1 (de) Lipidkomplexe von sehr unlöslichen platinkomplexen
DE69616523D1 (de) Verfahren zur baladung von lipidvesikeln
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
ATE223232T1 (de) Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
ATE273320T1 (de) Fusogene liposomen
FR2740686B1 (fr) Formulation pharmaceutique lyophilisee stable
ATE216590T1 (de) Arzneimittelformulierungen für il-12
EP1226109A4 (de) Phenylamin-carbonsäure-verbindungen und zubereitungen zur verabreichung von wirkstoffen
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
HUP0004396A2 (hu) A lipoprotein-oxidáció gátlására szolgáló, hatóanyagként hidroxilezett koleszterincsökkentő szert tartalmazó gyógyszerkészítmények
BG103552A (bg) Терапевтични средства
KR950700725A (ko) 리포솜 조성물(liposome composition)
HUP9900506A2 (hu) Protrombinszármazékok
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
FR2753707B1 (fr) Complexes nucleopeptidiques, compositions cosmetologiques et pharmaceutiques les contenant et utilisations
AU5129590A (en) New platinum complexes, their preparation and pharmaceutical compositions which contain them
FI893776A0 (fi) Transdermalt anvaendbara laekemedel innehaollande farmaceutiskt anvaendbara glykosider.
EE04093B1 (et) HIV proteaasi inhibiitorit VX 478 ja vees lahustuva vitamiin E derivaati vitamiin E-TPGSi sisaldavad preparaadid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975329

Country of ref document: EP

REN Ceased due to non-payment of the annual fee